News
Should COVID-19 vaccines be mixed?
According to The New York Times, health experts were “shocked” when the United Kingdom made a change to its guidelines in January to suggest that COVID-19 vaccines could be mixed.
COVID-19 Causes 'Unexpected' Cellular Response in the Lungs
New insights into the immune response to SARS-CoV-2 infections could bring better treatments for COVID-19 cases.
Evidence of Neuroinflammation in CSF of a COVID-19 Patient
While SARS-CoV-2 and similar coronaviruses are considered respiratory pathogens, a subset of patients with COVID-19 have presented with extrapulmonary disease along with neurological complications.
NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines
A clinical trial is underway to determine whether people who are highly allergic or have a mast cell disorder are at increased risk for an immediate, systemic allergic reaction to the Moderna or Pfizer-BioNTech COVID-19 vaccines.
Self-Reflection Can Make You a Better Leader
For many employees early in their career, the idea of one day becoming a leader in their workplace is a goal they hope to achieve, and they may even spend time envisioning themselves in the role.
FDA Approves First Trial Using CRISPR to Correct Sickle Cell Disease Mutation
UCSF, Berkeley, UCLA to launch sickle cell trial using CRISPR UC BERKELEY Scientists at UC San Francisco (UCSF), UC Berkeley, and UC Los Angeles (UCLA) have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
How Will Clinical Laboratories Collect Samples if Telehealth Replaces Traditional Doctor’s Office Visits?
Even before COVID-19, telehealth services were gaining in popularity. But the SARS-CoV-2 pandemic fully opened the door to widespread use of mobile healthcare (mHealth) technologies. This has had an on-going impact on clinical laboratories.
Expanded medication-assisted treatment significantly cost effective for opioid abuse
A substantial proportion of people with opioid use disorder in the United States have not received any form of medication-assisted treatment, according to results of a model-based cost-effectiveness analysis published in JAMA Psychiatry.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.